CTNM
Price
$4.41
Change
-$0.02 (-0.45%)
Updated
Jun 16, 12:33 PM (EDT)
Capitalization
114.61M
64 days until earnings call
KYMR
Price
$47.41
Change
+$0.45 (+0.96%)
Updated
Jun 16, 01:17 PM (EDT)
Capitalization
3.06B
46 days until earnings call
Interact to see
Advertisement

CTNM vs KYMR

Header iconCTNM vs KYMR Comparison
Open Charts CTNM vs KYMRBanner chart's image
Contineum Therapeutics
Price$4.41
Change-$0.02 (-0.45%)
Volume$200
Capitalization114.61M
Kymera Therapeutics
Price$47.41
Change+$0.45 (+0.96%)
Volume$200
Capitalization3.06B
CTNM vs KYMR Comparison Chart
Loading...
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTNM vs. KYMR commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a StrongBuy and KYMR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (CTNM: $4.43 vs. KYMR: $46.96)
Brand notoriety: CTNM and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 135% vs. KYMR: 51%
Market capitalization -- CTNM: $114.61M vs. KYMR: $3.06B
CTNM [@Biotechnology] is valued at $114.61M. KYMR’s [@Biotechnology] market capitalization is $3.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $356.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, CTNM is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • CTNM’s TA Score: 5 bullish, 4 bearish.
  • KYMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CTNM is a better buy in the short-term than KYMR.

Price Growth

CTNM (@Biotechnology) experienced а -6.74% price change this week, while KYMR (@Biotechnology) price change was -1.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.32%. For the same industry, the average monthly price growth was +9.92%, and the average quarterly price growth was +8.65%.

Reported Earning Dates

CTNM is expected to report earnings on Aug 19, 2025.

KYMR is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Biotechnology (-2.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.06B) has a higher market cap than CTNM($115M). KYMR YTD gains are higher at: 16.729 vs. CTNM (-69.761). CTNM has higher annual earnings (EBITDA): -50.16M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. CTNM (191M). CTNM has less debt than KYMR: CTNM (6M) vs KYMR (86.3M). KYMR has higher revenues than CTNM: KYMR (58.9M) vs CTNM (0).
CTNMKYMRCTNM / KYMR
Capitalization115M3.06B4%
EBITDA-50.16M-232.67M22%
Gain YTD-69.76116.729-417%
P/E Ratio26.40N/A-
Revenue058.9M-
Total Cash191M463M41%
Total Debt6M86.3M7%
TECHNICAL ANALYSIS
Technical Analysis
CTNMKYMR
RSI
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
88%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 26 days ago
71%
N/A
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QBUF27.560.06
+0.22%
Innovator Nasdaq-100 10 Buffr ETF - Qt
CLOZ26.69-0.02
-0.07%
Eldridge BBB-B CLO ETF
DFJ85.06-0.75
-0.87%
WisdomTree Japan SmallCap Dividend ETF
AIEQ40.80-0.40
-0.98%
Amplify AI Powered Equity ETF
FELC33.25-0.39
-1.16%
Fidelity Enhanced Large Cap Core ETF

CTNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTNM has been loosely correlated with CCCC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CTNM jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
-4.32%
CCCC - CTNM
37%
Loosely correlated
+3.70%
VYGR - CTNM
30%
Poorly correlated
-8.33%
XNCR - CTNM
30%
Poorly correlated
-2.55%
NRIX - CTNM
30%
Poorly correlated
-0.25%
KYMR - CTNM
29%
Poorly correlated
-0.70%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-0.70%
CCCC - KYMR
64%
Loosely correlated
+3.70%
NRIX - KYMR
62%
Loosely correlated
-0.25%
VERA - KYMR
54%
Loosely correlated
+0.98%
CGON - KYMR
54%
Loosely correlated
-2.42%
RVMD - KYMR
54%
Loosely correlated
-1.26%
More